Filing Details

Accession Number:
0001765581-22-000126
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-25 21:33:16
Reporting Period:
2022-11-22
Accepted Time:
2022-11-25 21:33:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253886 G Patrick Enright 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-11-22 2,905 $149.18 21,181 No 4 S Direct
Ordinary Shares Disposition 2022-11-22 2,069 $149.90 19,112 No 4 S Direct
Ordinary Shares Disposition 2022-11-22 2,000 $152.88 0 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect by Trust
Footnotes
  1. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.51 to $149.34. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  2. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.76 to $150.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.84 to $152.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. These shares were held by a trust (the "Trust"). Reporting person is the Trustee of the Trust and may be deemed to share voting, investment and dispositive power over the shares held by the Trust. Reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.